Tardive Dyskinesia
Tardive Dyskinesia (TD) is a movement disorder resulting from prolonged use of certain medications, often with psychiatric implications. The Journal of Clinical Psychiatry offers comprehensive insights into TD, from its pathophysiology to management strategies. Our expert editors ensure that the content is both clinically relevant and actionable, aiding psychiatrists in diagnosing, preventing, and treating this challenging condition.
NEWS
This week features a rare report of phentermine-induced tardive dyskinesia, research on suicide neural markers, and maternal mental health.
ORIGINAL RESEARCH
Accurately identifying the severity and functional impact of tardive dyskinesia is essential. This report describes a new instrument, the Clinician’s Tardive Inventory, which aims to address shortcomings of existing instruments.
J Clin Psychiatry 2024;85(1):23m14886
Richard M. Trosch and others
NEWS
An expert explains the mechanism, risk factors, progression, and quality of life implications of Tardive Dyskinesia.
NEWS
Some emerging therapies and treatment options hold promise in Rett Syndrome, a rare neurodevelopmental disorder that primarily affects girls.
NEWS
A panel of experts has developed an easy-to-use scale to assess the symptoms and challenges of having tardive dyskinesia.
ORIGINAL RESEARCH
This survey reveals the substantial burden of tardive dyskinesia on people’s lives and on the management of their underlying condition.
J Clin Psychiatry 2023;84(3):22m14694
Rakesh Jain and others
CONSENSUS STATEMENT
This easy-to-use scale developed by 7 experts measures the impact of TD on patients’ daily functioning.
J Clin Psychiatry 2023;84(1):22cs14563
Richard Jackson and others
ORIGINAL RESEARCH
This study compared spontaneous reporting of tardive dyskinesia with long-acting injectable versus oral antipsychotics.
J Clin Psychiatry 2022;83(5):21m14304
Fuminari Misawa and others
ORIGINAL RESEARCH
This study examined clinician documentation of tardive dyskinesia in a large electronic medical record database from a single large community mental health treatment center.
Prim Care Companion CNS Disord 2022;24(4):21m03069
Carol S. North and others
FREE CME: E-REPORT
Can you recognize risk factors for tardive dyskinesia? Are you familiar with diagnostic criteria? Do you regularly assess patients for the condition? Are you knowledgeable about using new medications for TD? Experts share best practices for the assessment and treatment of TD.
J Clin Psychiatry 2021;82(6):NU20016AX1C
Christoph U. Correll and others
MY ACCOUNT
